Analgesics: Market Research Report

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 [email protected] http://marketpublishers.com

Phone: +44 20 8123 2220 http://marketpublishers.com

Analgesics: Market Research Report Date: Pages: Price: ID:

October 1, 2010 767 US$ 4,500.00 A96AACC324FEN

This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others (includes combination drugs)), and External Analgesics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 137 companies including many key and niche players such as Bayer Consumer Care, Johnson & Johnson, McNeil Consumer Healthcare, Novartis International AG, Pfizer, Inc., Reckitt Benckiser Group Plc, and Sanofi Aventis S.A. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Content 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations Disclaimers Data Interpretation & Reporting Level Quantitative Techniques & Analytics Product Definitions and Scope of Study 1. INTERNAL ANALGESICS Aspirin Acetaminophen Ibuprofen Others 2. EXTERNAL ANALGESICS 2. GLOBAL ANALGESICS MARKET OVERVIEW Pain Therapeutic Market Analgesics Market - Offering Immense Potential Internal Analgesics – The Largest & Fastest Growing Market Liquid Analgesics Register Rapid Growth

Analgesics: Market Research Report

2

Phone: +44 20 8123 2220 http://marketpublishers.com

Neuropathic Pain - Unexplored Ibuprofen Scoring High External Analgesics – Loosing Sheen Topical Analgesics Market: Current Picture Competitive Scenario Global Analgesics Market (2007): Leading Analgesics Brands by Manufacturer 3. PRODUCT OVERVIEW A Brief History Analgesics Definition Types of Pain Acute Pain Chronic Pain Drugs Combating Pain Local Anesthetics Narcotic Opioids Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Types of NSAIDS Common NSAIDs Clinical Use... Side Effects... Aspirin The Wonder Drug... PolyAspirin: The Safer and More Potent Polymer Variant of Aspirin Mode of Action Contraindications Acetaminophen Acetaminophen Protects Heart Muscle Acetaminophen Reduces Incidence of Ovarian Cancer Ibuprofen, Ketoprofen and Naproxen Combination Analgesics

Table 1. Opioid Analgesics Market: Percentage Share of Opioid / Acetaminophen Combination Products in the Opioid Script Volume (includes corresponding Graph/Chart) OTC Analgesics: An Overview 4. INDUSTRY DYNAMICS Escalating R&D Costs: A Boon or Bane? Timeline of the Drug Approval Process Cox II Crisis Tarnishes Industry Growth Novel Therapies to Propel Opioid and Non-Opioid Therapies Rx-to-OTC Switch Why Consumers Prefer OTC Drugs? Development of Analgesic Tripeptides 5. RECENT CLINICAL TRIALS PLx Initiates Clinical Trial For Aspirin-PC Neurodiscovery Receives Approval for NSL-101 Phase II Clinical Trials

Analgesics: Market Research Report

3

Phone: +44 20 8123 2220 http://marketpublishers.com

6. PRODUCT INTRODUCTIONS/INNOVATIONS Victory Pharma Unveils Naprelan Dose Card Nutra Pharma Commences Online Sales of Cobroxin Nutra Pharma to Introduce Nyloxin Rx Dr Reddy’s Rolls Out Finrid MIP Technologies and Supelco Introduce Unique SPE Product Novartis Introduces Voltaren AC Product Line ProEthic Pharmaceuticals Releases Ibudone for Acute Pain Management Dr. Reddy’s Laboratories Introduces Supanac for Acute Pain Management Teva Pharmaceutical Announces the Launch of Fentanyl Transdermal System Dr. Reddy's Laboratories Introduces Supanac NSAID Drug 7. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER Mallinckrodt Introduces Magnacet™ Tablets for Pain Management Wockhardt to Launch New Painkiller Paladin Labs and Labopharm Introduce Tridural™ Shionogi & Co Introduces OxiNorm Powder 0.5% McNeil Brings Chewable TYLENOL® GoTabs Tablets Barr Unveils Generic Version of ACTIQ® Novartis Launches Voltarol Pain-Eze Emulgel. TheraQuest Launches TQ-1017 Mentholatum Company Introduces WellPatch Deep Heat Patch… 8. PRODUCT APPROVALS Par Pharmaceutical Secures Approval for Marketing Tramadol ER Cipher Acquires Tentative Approval for Tramadol ER Capsules Lannett Receives Approval for Developing Hydromorphone Hydrochloride Tablets King Pharmaceuticals Receives Approval for Embeda Pain-Relief Capsules Sangart Secures EC’s Orphan Drug Designation for MP4CO Biovail Secures Canadian Approval for Ralivia Elite Pharmaceuticals and PharmaNetwrok Receive FDA Approval 9. RECENT INDUSTRY ACTIVITY China Life Insurance Inks Agreement with Sino Biopharmaceutical Azur Pharma Inks Agreement with Elan Pharmaceuticals Pfizer Acquires Wyeth Taisho Pharmaceutical Takes Over OTC Drugs Business of Bristol-Myers Squibb Piramal Healthcare Acquires Minrad International Biocon Acquires Bulk Pharmaceuticals Unit of Hindujas Abbott Acquires PG110 from PanGenetics Sanofi-aventis Mexico Takes Over Laboratorios Kendrick WraSer Acquires e5 Pharma’s Trezix Astellas Acquires Exclusive rights to Pain-Relief Drug from Neuroges Henan Lingrui Pharma Commences Construction of New Analgesic Factory Labopharm Europe Enters into Agreement with Merck Sharp & Dohme Cumberland Pharmaceuticals Enters into a Commercialization Agreement with DB Pharm Korea Cumberland Pharmaceuticals Inks an Exclusive Agreement with Phebra Mallinckrodt Acquires Rights of Exalgo Extended-Release Tablets from Neuromed Labopharm Europe and Grunenthal Sign Distribution and Supply Agreement Timm Medical and Ferring Co-promote Prosed DS in the US Competitive Technologies and Fintrade Medical Ink Sales and Distribution Agreement

Analgesics: Market Research Report

4

Phone: +44 20 8123 2220 http://marketpublishers.com

Accumetrics and Endotech Ink Exclusive Distribution Agreement Astellas and NeurogesX Sign Distribution and Marketing Agreement Akela Pharma Inks Agreement with Teikoku Seiyaku Medical Nutrition Inks Exclusive Licensing Agreement with DSE Healthcare Echo Therapeutics Inks a Licensing Deal with Ferndale Pharma Circ Pharma Signs a Development Agreement with Elan Orexo Inks Distribution Agreement with Neopharm Orexo Inks Agreement with NovaMed Pharmaceuticals Pharmos and Reperio Enter into Agreement Caraco Pharmaceutical Launches Oxycodone Hydrochloride Tablet Purdue Pharma Provides Labopharm’s RYZOLT Bayer Acquires Sagmel’s OTC Business E5 Pharma Receives Approval from FDA Pharmaceutical Associates Receives Approval from FDA Concord Receives New Drug Approvals Hisamitsu Receives Approval for SALONPAs® Johnson & Johnson Submits NDA to FDA Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural Akela Extends Agreement with Janssen Daiichi and Lead Chemical Receives Approval for Loxonin( Tape Tokio Marine Capital Acquires Showa Yakuhin Kako Corgenix Collaborates with Randox Laboratories Corgenix Receives EPO Approval for Aspirin Resistance Method IOL to Expand Production Capacity American Oriental Bioengineering Partners with China Aoxing Abraxis Takes Over Shimoda and its Subsidiary Company Church & Dwight Snaps Up Del Pharmaceuticals from Coty Sosei Group Corp Re-Acquires Rights to Commercialize AD 923 ProStrakan Group Inks Agreement with Paladin Labs Anika Therapeutics Inks Distribution Agreement with DePuy Mitek Wyeth Acquires ThermaCare Brand from P&G Albemarle Appoints Dr. Reddy’s as Distributor of Bulk Ibuprofen API Competitive Technologies and ELS Join Forces to Distribute Pain Management Device Altea Therapeutics Partners with Hospira Paladin Inks Co-Promotion Deal with Nycomed AstraZeneca to Divest OTC Portfolio 10. CORPORTAE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER Ranbaxy Receives Approval from FDA Wockhardt Receives FDA Approval for DPN + APAP Alpharma to Market Flector® Patch in the US Auriga and Mikart Inks Agreement to Market Codein Watson Receives FDA Approval for Oxycodone Hydrochloride and Ibuprofen Labopharm’s Tramadol Receives Approval in Canada Lion Acquires BUFFERIN® Trademark Rights Grunenthal’s Extends Licensing Agreement with Ortho-McNeil China Aoxing Pockets LRT Anesiva Inks Joint Venture Agreement Wanbang Beijing Med-Pharm Inks Agreement with Lotus Healthcare LAB International Inks Licensing Agreement with Janssen Pharmaceutica Three Sixty Pockets Rockford-Montgomery Labs Antares Enters into License and Development Agreement for Opioid Analgesic Abraxis BioScience Acquires AstraZeneca’s Analgesic Brand Portfolio IntelliPharmaCeutics Inks Agreement with Larasan

Analgesics: Market Research Report

5

Phone: +44 20 8123 2220 http://marketpublishers.com

Ranbaxy and Ethypharm Ink In-licensing Agreement Elite Collaborates with TPN to Co-develop Analgesic Drug Novartis Acquires Hexal Company and Major Stake in Eon Labs…. NovaDel Pharma Receives Patent for Buccal Sprays Technology Auxilium Pharmaceuticals Enters into a Licensing Agreement with PharmaForm… EC Sanctions Sale of Elan’s Prialt EpiCept Corp. Merges with Maxim Pharmaceuticals, Inc Reckitt Benckiser plc Acquires Boots Healthcare International… 11. FOCUS ON SELECT KEY PLAYERS Bayer Consumer Care (US) Johnson & Johnson (US) McNeil Consumer Healthcare (Canada) Novartis International AG (Switzerland) Pfizer Inc. (US) Reckitt Benckiser Group Plc (UK) Sanofi Aventis S.A. (France) 12. GLOBAL MARKET PERSPECTIVE

Table 2. World Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 3. World Historic Review for Analgesics by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 4. World 11-Year Perspective for Analgesics by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015(includes corresponding Graph/Chart) Table 5. World Recent Past, Current & Future Analysis for Internal Analgesics by Geographic Region/ Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 6. World Historic Review for Internal Analgesics by Geographic Region / Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 7. World 11-Year Perspective for Internal Analgesics by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) Table 8. World Recent Past, Current & Future Analysis for Internal Analgesics by Product Segment – Aspirin, Acetaminophen, Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 9. World Historic Review for Internal Analgesics by Product Segment – Aspirin, Acetaminophen,

Analgesics: Market Research Report

6

Phone: +44 20 8123 2220 http://marketpublishers.com

Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 10. World 11-Year Perspective for Internal Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Aspirin, Acetaminophen, Ibuprofen, and Others Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) Table 11. World Recent Past, Current & Future Analysis for Aspirin by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 12. World Historic Review for Aspirin by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 13. World 11-Year Perspective for Aspirin by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010& 2015 (includes corresponding Graph/Chart) Table 14. World Recent Past, Current & Future Analysis for Acetaminophen by Geographic Region/ Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 15. World Historic Review for Acetaminophen by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 16. World 11-Year Perspective for Acetaminophen by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010 & 2015 (includes corresponding Graph/Chart) Table 17. World Recent Past, Current & Future Analysis for Ibuprofen by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 18. World Historic Review for Ibuprofen by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 19. World 11-Year Perspective for Ibuprofen by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010 & 2015 (includes corresponding Graph/Chart) Table 20. World Recent Past, Current & Future Analysis for Other Internal Analgesics by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 21. World Historic Review for Other Internal Analgesics by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets

Analgesics: Market Research Report

7

Phone: +44 20 8123 2220 http://marketpublishers.com

Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 22. World 11-Year Perspective for Other Internal Analgesics by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015 (includes corresponding Graph/Chart) Table 23. World Recent Past, Current & Future Analysis for External Analgesics by Geographic Region/ Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 2015 (includes corresponding Graph/Chart) Table 24. World Historic Review for External Analgesics by Geographic Region / Country – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2007 (includes corresponding Graph/Chart) Table 25. World 11-Year Perspective for External Analgesics by Geographic Region /Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015(includes corresponding Graph/Chart) 13. THE UNITED STATES A. Market Analysis Current and Future Analysis Pain Statistics in the US Industry Overview Internal Analgesics Cox-2 Drugs in for Some Trouble Switch to OTC Drugs

Table 26. US Analgesics Market (2009): Percentage Share Breakdown of Leading Manufacturers by Sales (includes corresponding Graph/Chart) Table 27. US Internal Liquid Analgesics Market (2009): Percentage Share Breakdown of Leading Brands by Sales (includes corresponding Graph/Chart) Table 28. US Internal Tablet Analgesics Market (2009): Percentage Share Breakdown of Leading Brands by Sales (includes corresponding Graph/Chart) Table 29. Internal Analgesics Market in the US by Retail Channel (2008): Percentage Share by Value Sales for Discount Stores, Food/Drug Combination Stores, Chain Drug Stores, Supermarkets, and Independent Drug Stores (includes corresponding Graph/Chart) Promotional Strategies for the Internal Analgesics

Table 30. Market for Internal Liquid Analgesics in the U.S. by Retail Channel (2008): Percentage Share by Value Sales for Supermarkets, Drug Stores, and Discounters (includes corresponding Graph/Chart) Pediatric Analgesics: The New Kid on the Block External Analgesics Stretching Boundaries

Analgesics: Market Research Report

8

Phone: +44 20 8123 2220 http://marketpublishers.com

Table 31. US External Analgesics Market (2007): Percentage Share Breakdown of Leading Ten Brands by Revenues (includes corresponding Graph/Chart) Table 32. External Analgesics Market in the US by Retail Channel (2008): Percentage Share by Value Sales for Chain drug stores, Discount stores, Food/drug combination stores, Independent drug stores, and Supermarkets (includes corresponding Graph/Chart) Rubs, Patches: Driving the External Analgesics Market Patch Relief…Gaining Momentum B. Market Analytics

Table 33. US Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 34. US Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 35. US 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 14. CANADA Market Analysis

Table 36. Canadian Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 37. Canadian Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 38. Canadian 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 15. JAPAN A. Market Analysis Current and Future Analysis Competitive Scenario in the Past

Table 39. OTC Analgesics Market in Japan (2005): Market Share of Leading Players by Value – Lion, Arax, Taisho Pharmaceutical, SS Pharmaceutical, Shionogi, and Others (includes corresponding Graph/Chart)

Analgesics: Market Research Report

9

Phone: +44 20 8123 2220 http://marketpublishers.com

B. Market Analytics

Table 40. Japanese Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 41. Japanese Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 42. Japanese 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart) 16. EUROPE A. Market Analysis Current and Future Analysis By Product Group/Segment European Pain Management Market Generics Restrain Revenue Growth Popular Brands in 2004

Table 43. Popular Brands of Pain & Inflammation Medication in Europe (2004): Percentage Share of Aspirin, Voltaren, Ibuprofen, Nurofen, Vioxx, Celebre, Tylenol, Aulin, Anadin, and Paracetamol (includes corresponding Graph/Chart) B. Market Analytics

Table 44. European Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country – France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 45. European Historic Review for Analgesics by Geographic Region/Country – France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 46. European 11-Year Perspective for Analgesics by Geographic Region/Country – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) Table 47. European Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 48. European Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2007 (includes corresponding Graph/Chart) Table 49. European 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of

Analgesics: Market Research Report

10

Phone: +44 20 8123 2220 http://marketpublishers.com

Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 16A.FRANCE A. Market Analysis Current and Future Analysis Competitive Scenario

Table 50. Analgesics Market in France (2005): Market Share of Leading Players by Value – Bristol-Myers Squibb, Therapix, Roche, Bayer Group, Wyeth Consumer Healthcare, and Others) (includes corresponding Graph/Chart) B. Market Analytics

Table 51. French Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 52. French Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 53. French 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 16B.GERMANY A. Market Analysis Current and Future Analysis Competitive Scenario

Table 54. Analgesics Market in Germany (2005): Market Share of Leading Players by Value – Bayer Group, Boehringer Ingelheim, Wyeth Consumer Healthcare, and Others (includes corresponding Graph/Chart) B. Market Analytics

Table 55. German Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 56. German Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 57. German 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics: Market Research Report

11

Phone: +44 20 8123 2220 http://marketpublishers.com

Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 16C.ITALY A. Market Analysis Current and Future Analysis Competitive Scenario

Table 58. Analgesics Market in Italy (2005): Market Share of Leading Players by Value – Bayer Group, Angelini, Novartis, Bristol-Myers Squibb, and Others (includes corresponding Graph/Chart) B. Market Analytics

Table 59. Italian Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 60. Italian Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 61. Italian 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart) 16D.THE UNITED KINGDOM A. Market Analysis Current and Future Analysis An Overview of Analgesics Market in the UK Distribution Scenario Competitive Scenario

Table 62. Analgesics Market in the United Kingdom (2005E): Market Shares of Leading Players by Value – Boots Healthcare, GlaxoSmithKline, and Others (includes corresponding Graph/Chart) B. Market Analytics

Table 63. UK Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 64. UK Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 65. UK 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005,2010 & 2015(includes corresponding Graph/Chart)

Analgesics: Market Research Report

12

Phone: +44 20 8123 2220 http://marketpublishers.com

16E.SPAIN A. Market Analysis Current and Future Analysis Competitive Scenario

Table 66. Analgesics Market in Spain (2005): Market Share of Leading Players by Value – Bayer Group, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Boots Healthcare, and Others (includes corresponding Graph/Chart) B. Market Analytics

Table 67. Spanish Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 68. Spanish Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart) Table 69. Spanish 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart) 16F.REST OF EUROPE Market Analysis

Table 70. Rest of Europe Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 71. Rest of Europe Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 72. Rest of Europe 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 17. ASIA-PACIFIC A. Market Analysis Current and Future Analysis The OTC Analgesic Market OTC Analgesics Market in Asia-Pacific (2004): A Comparative Analysis of the Major Regions – Australia, China and South Korea B. Market Analytics

Analgesics: Market Research Report

13

Phone: +44 20 8123 2220 http://marketpublishers.com

Table 73. Asia-Pacific Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) Table 74. Asia-Pacific Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 75. Asia-Pacific 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005,2010 & 2015(includes corresponding Graph/Chart) 18. LATIN AMERICA Market Analysis

Table 76. Latin American Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 77. Latin American Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 78. Latin American 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015(includes corresponding Graph/Chart) 19. REST OF WORLD Market Analysis

Table 79. Rest of World Recent Past, Current & Future Analysis for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 80. Rest of World Historic Review for Analgesics by Product Segment – Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 81. Rest of World 11-Year Perspective for Analgesics by Product Segment – Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 20.APPENDIX – POPULAR ANALGESIC BRANDS BY REGION Canada France

Analgesics: Market Research Report

14

Phone: +44 20 8123 2220 http://marketpublishers.com

Germany United Kingdom Leading Analgesics Brands for Children Italy Spain Rest of Europe Asia-Pacific Latin America Competition Total Companies Profiled: 137 (including Divisions/Subsidiaries - 179) Region/CountryPlayers The United States Canada Japan Europe France Germany The United Kingdom Italy Spain Rest of Europe Asia-Pacific (Excluding Japan) Middle East Africa

Please read Global Industry Analysts, Inc., - Sales Policy below before placing an order: All Publications from Global Industry Analysts, Inc., (GIA) are protected per protocols of the Universal Copyrights Convention and the United States Copyrights Office. It is GIA’s policy that once purchased, these publications may not be returned for any reason. GIA makes all reasonable attempts to report current and accurate information in its publications. GIA will not be responsible for any type of damages (financial or other) incurred by the client (company or individual) in the usage of GIA’s publications or services. The client agrees that in case a legal resolution becomes necessary, the venue shall be the city of San Francisco, California, USA. Under any circumstances, GIA’s liability shall be limited to the exact price of the product or service paid to GIA by the client. This publication is sold as a single-user single-site license. Electronic versions operate like normal PDF files once installed and permit unlimited print and cut & paste. Digital controls and watermarks are set on electronic copies and are protected against copying. Extra licenses can be purchased for the same location at 10% of the list price.

Analgesics: Market Research Report

15

Powered by TCPDF (www.tcpdf.org)

Phone: +44 20 8123 2220 http://marketpublishers.com

I would like to order: Product name: Product link: Product ID: Price:

Analgesics: Market Research Report http://marketpublishers.com/r/A96AACC324FEN.html A96AACC324FEN US$ 4,500.00 (Single User License / Electronic Delivery)

If you want to order Corporate License or Hard Copy, please, contact our Customer Service: [email protected]

Payment To pay by Credit Card (Visa, MasterCard, American Express, PayPal), please, click 'BUY NOW' button on product page http://marketpublishers.com/r/A96AACC324FEN.html

To pay by Wire Transfer, please, fill in your contact details in the form below: First name: Last name: E-mail: Company: Address: City: Zip/Post Code: Country: Tel: Fax: Your message:

* All fields are required

Customer Signature _______________________________________ Please, note that by ordering from MarketPublisher.com you are agreeing to our Terms & Conditions at http://marketpublishers.com/docs/terms_conditions.html

To place an order via fax simply print this form, fill in the information below and fax the completed form to +44 20 7900 3970